LAG3 and neoplasm: As for the immune-activating effects associated with LAG3 expression in CD4 + T cells in the treated tissues of this study, we propose that this reflects the presence of more surviving tumor-killing cells, such as activated effector T cells, in the local tumor microenvironment (TME) under CCRT-induced damage.